Maternal anxiety about first trimester nuchal translucency screening and impact of positive screening results

References

• Chasen ST, Sharma G, Kalish RB, Chervenak FA. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population. Ultrasound Obstet Gynecol. 2003; 22: 149–51
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol. 2005; 25: 221–6
   PubMed Web of Science ®Google Scholar
• Valinen Y, Rapakko K, Kokkonen H, Laitinen P, Tekay A, Ahola T, et al. Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in northern Finland. Am J Obstet Gynecol. 2007; 196: 278.e1–5
   PubMed Web of Science ®Google Scholar
• Weinans MJ, Kooij L, Muller MA, Bilardo KM, Van Lith JM, Tymstra T. A comparison of the impact of screen-positive results obtained from ultrasound and biochemical screening for Down syndrome in the first trimester: a pilot study. Prenat Diagn. 2004; 24: 347–51
   PubMed Web of Science ®Google Scholar
• Kaiser AS, Ferris LE, Pastuszak AL, Llewellyn-Thomas H, Johnson JA, Conacher S, et al. The effects of prenatal group genetic counselling on knowledge, anxiety and decisional conflict: issues for nuchal translucency screening. J Obstet Gynaecol. 2002; 22: 246–55
   PubMedGoogle Scholar
• Kaiser AS, Ferris LE, Katz R, Pastuszak A, Llewellyn-Thomas H, Johnson JA, et al. Psychological responses to prenatal NTS counseling and the uptake of invasive testing in women of advanced maternal age. Patient Educ Couns. 2004; 54: 45–53
   PubMed Web of Science ®Google Scholar
• Chan LW, Chau MC, Leung TY, Fung TY, Leung TN, Lau TK. Expectation and knowledge of women undergoing first-trimester combined screening for Down syndrome in a Chinese population. Prenat Diagn. 2005; 25: 1248–52
   PubMed Web of Science ®Google Scholar
• Muller MA, Bleker OP, Bonsel GJ, Bilardo CM. Nuchal translucency screening and anxiety levels in pregnancy and puerperium. Ultrasound Obstet Gynecol. 2006; 27: 357–61
   PubMed Web of Science ®Google Scholar
• Cheng PJ, Chang SD, Shaw SW, Soong YK. Nuchal translucency thickness in fetuses with chromosomal translocation at 11–12 weeks of gestation. Obstet Gynecol. 2005; 105: 1058–62
   PubMed Web of Science ®Google Scholar
• Cheng PJ, Shaw SW, Soong YK. Association of fetal choroid plexus cysts with trisomy 18 in a population previously screened by nuchal translucency thickness measurement. J Soc Gynecol Invest. 2006; 13: 280–4
   PubMedGoogle Scholar
• Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol. 2004; 191: 45–67
   PubMed Web of Science ®Google Scholar
• Loo R. The State-Trait Anxiety Inventory A-Trait Scale: dimensions and their generalization. J Pers Assess. 1979; 43: 50–3
   PubMed Web of Science ®Google Scholar
• Abuelo DN, Hopmann MR, Barsel-Bowers G, Goldstein A. Anxiety in women with low maternal serum alpha-fetoprotein screening results. Prenat Diagn. 1991; 11: 381–5
   PubMed Web of Science ®Google Scholar
• Marteau TM, Cook R, Kidd J, Michie S, Johnston M, Slack J, et al. The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn. 1992; 12: 205–14
   PubMed Web of Science ®Google Scholar
• Georgsson OS, Saltvedt S, Grunewald C, Waldenstrom U. Does fetal screening affect women's worries about the health of their baby? A randomized controlled trial of ultrasound screening for Down's syndrome versus routine ultrasound screening. Acta Obstet Gynecol Scand. 2004; 83: 634–40
   PubMed Web of Science ®Google Scholar
• Goel V, Glazier R, Summers A, Holzapfel S. Psychological outcomes following maternal serum screening: a cohort study. CMAJ. 1998; 159: 651–6
   PubMed Web of Science ®Google Scholar
• Rausch DN, Lambert-Messerlian GM, Canick JA. Participation in maternal serum screening following screen positive results in a previous pregnancy. J Med Screen. 2000; 7: 4–6
   PubMed Web of Science ®Google Scholar
• Weinans MJ, Kooij L, Muller MA, Bilardo KM, Van Lith JM, Tymstra T. A comparison of the impact of screen-positive results obtained from ultrasound and biochemical screening for Down syndrome in the first trimester: a pilot study. Prenat Diagn. 2004; 24: 347–51
   PubMed Web of Science ®Google Scholar
• Muller MA, Bleker OP, Bonsel GJ, Bilardo CM. Women's opinions on the offer and use of nuchal translucency screening for Down syndrome. Prenat Diagn. 2006; 26: 105–11
   PubMed Web of Science ®Google Scholar
• Dipietro JA, Irizarry RA, Costigan KA, Gurewitsch ED. The psychophysiology of the maternal-fetal relationship. Psychophysiology. 2004; 41: 510–20
   PubMed Web of Science ®Google Scholar